Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus versus continuous infusion tranexamic acid in abdominal myomectomy
PACTR202512619740287Completed
- Sponsor
- Oluwakemi Windapo
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in Fibromyoma (LM), sponsored by Oluwakemi Windapo. Primary endpoint: Intra-operative blood loss. Started Mar 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202512619740287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512619740287.